Table 2 SNV and SV calls affecting SETD2

From: Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2

SETD2 single nucleotide variants

DOG ID

Chromosome

Position

Reference allele

Alternate allele

Effect

Status

Coding nucleotide

Amino acid

2

20

41,762,908

A

AG

Frameshift

Somatic

c.6121dupG

p.Asp2041fs

7

20

41,723,954

A

T

Missense

Somatic

c.4991A > T

p.Tyr1664Phe

7

20

41,763,013

C

T

Stop gained

Somatic

c.6223C > T

p.Arg2075*

16

20

41,713,105

CAG

C

Frameshift

Somatic

c.3399_3400delGA

p.Asn1135fs

16

20

41,723,904

G

GT

Frameshift

Somatic

c.4947dupT

p.Thr1650fs

24

20

41,710,750

C

CA

Frameshift

Somatic

c.1046dupA

p.Ser350fs

14

20

41,711,731

CT

C

Frameshift

Somatic

c.2022delT

p.Ala676fs

14

20

41,737,948

TA

T

Frameshift

Somatic

c.5432delA

p.Asn1811fs

21

20

41,712,888

C

T

Missense

Germline

c.3178C > T

p.Arg1060Cys

SETD2 structural variants

DOG ID

Chromosome start

Start position

Chromosome end

End position

SV type

Status

Effect

 

6

20

41,777,850

6

63,389,989

BND

Somatic

Transcript ablation

 

8

20

41,707,519

20

41,725,779

DEL

Somatic

Exon loss

 

9

20

41,677,050

20

57,146,991

INV

Somatic

Inversion

 

12

20

40,619,935

20

41,682,808

DUP

Somatic

Frameshift & splice variant

 

9

20

41,793,070

20

44,196,596

INV

Somatic

Bidirectional gene fusion

 

12

20

41,797,955

4

51,687,909

BND

Somatic

Gene fusion & frameshift

 

17

20

41,586,296

20

41,760,821

DEL

Somatic

Feature ablation

 
  1. SNV single nucleotide variant, SV structural variant